Improvement of Chronic Spontaneous Urticaria After Glucagon-Like Peptide 1 Receptor Agonist Therapy: Report of Two Cases
Abstract Chronic spontaneous urticaria (CSU) is a mast cell-driven disease that affects approximately 1% of the population. Second-generation non-sedating H1-antihistamines (H1AH) are considered the first-line treatment; however, a substantial proportion of patients remain refractory and require alt...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Adis, Springer Healthcare
2026-01-01
|
| Serier: | Dermatology and Therapy |
| Fag: | |
| Online adgang: | https://doi.org/10.1007/s13555-025-01640-7 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
